Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Study 2 (NCT 00435136) This study re-randomized 177 HIV-infected patients with lipodystrophy who completed EGRIFTA treatment in the Main Phase to receive either a 2 mg dose of EGRIFTA (1 mg/vial formulation) (N=92) or placebo (N=85) for an additional 26-week duration (1:1 randomization ratio)
This may theoretically offer a more sustained window of availability to tissues like the liver and kidney that can actually utilize circulating glutathione
Foods rich in vitamin C: Vitamin C is one of the bodys most important antioxidants and works closely with glutathione [2]
Storage & Handling: Store lyophilized powder at -20C For laboratory research use only: Reconstitute with appropriate research-grade sterile diluent per your experimental protocol
US$ 29.96
US$ 27.57
US$ 20.03
US$ 22.84
US$ 26.55
US$ 24.14
